Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification

PURPOSE: To compare the efficacy of a once-daily dose of 0.3% nepafenac and three times daily dose of 0.1% nepafenac in controlling pain and inflammation following phacoemulsification. METHODS: In this prospective randomized control single-blind study. patients who underwent uneventful phacoemulsifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bardoloi, Narayan, Sarkar, Sandip, Burgute, Pankaj Suresh, Deb, Amit Kumar, Dholkawala, Roshni, Aggarwal, Priyal, Gokhale, Tanmay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114608/
https://www.ncbi.nlm.nih.gov/pubmed/35225519
http://dx.doi.org/10.4103/ijo.IJO_2401_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114608/
https://www.ncbi.nlm.nih.gov/pubmed/35225519
http://dx.doi.org/10.4103/ijo.IJO_2401_21

Ejemplares similares